Drugs / BIOHM
last change Mar 2026 re-read 3 minutes ago

BIOHM

Other / unclassified

Developed for
breast cancer
Investigated by
Case Comprehensive Cancer Center

Trials 1

PhaseRegistry idDatesIndicationSponsorStatusOutcome
— NCT04362826 Mar → Dec 2026 expected breast cancer Case Comprehensive Cancer Center Recruiting No outcome recorded

Evidence & citations 2 cited values

Every value below carries the sentence it was read from. 1 source stands behind the page.

FieldValueCited text
Known as BIOHM “The probiotic, BIOHM, which is owned and distributed by BIOHM Health LLC, will be used in this study.” NCT04362826 ↗
Modality Other / unclassified “BIOHM is a food supplement” NCT04362826 ↗